Loading...
Monitoring response and resistance to treatment in chronic myeloid leukemia
Chronic myeloid leukemia (cml) results from expression of the constitutive tyrosine kinase activity of the Bcr-Abl oncoprotein. Imatinib, a tyrosine kinase inhibitor (tki), is highly effective in the treatment of cml. However, some patients treated with imatinib will fail to respond, will respond su...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Multimed Inc.
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3070714/ https://ncbi.nlm.nih.gov/pubmed/21505592 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|